Amol Penshanwar

Amol Penshanwar is an experienced regulatory affairs professional with a strong background in Chemistry, Manufacturing, and Controls (CMC). Currently serving as Associate Director of Regulatory Affairs CMC at Sarepta Therapeutics since May 2023, Amol has previously held positions including Senior Manager of Regulatory Affairs - CMC at Moderna, Manager of Global Regulatory Affairs - CMC Biologics at Takeda, and Senior Regulatory Affairs Associate - CMC at Sanofi Genzyme. Amol began the career as a Regulatory Affairs Intern at NxStage Medical and has worked in various regulatory roles at Lantheus and Anholt Technologies. Amol holds a Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University and a Bachelor of Science in Pharmacy from Amravati University.